4//SEC Filing
ARCH VENTURE FUND V LP 4
Accession 0001012975-11-000224
CIK 0001385830other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 9:09 PM ET
Size
20.8 KB
Accession
0001012975-11-000224
Insider Transaction Report
Form 4
NeurogesX IncNGSX
NELSEN ROBERT
Director
Transactions
- Purchase
Common Stock
2011-07-21$1.65/sh+1,744,186$2,877,907→ 4,187,777 total - Purchase
Warrant
2011-07-21$0.14/sh+872,093$122,093→ 872,093 totalExercise: $1.65Exp: 2016-07-26→ Common Stock (872,093 underlying)
ARCH VENTURE FUND V LP
10% Owner
Transactions
- Purchase
Warrant
2011-07-21$0.14/sh+872,093$122,093→ 872,093 totalExercise: $1.65Exp: 2016-07-26→ Common Stock (872,093 underlying) - Purchase
Common Stock
2011-07-21$1.65/sh+1,744,186$2,877,907→ 4,187,777 total
ARCH VENTURE PARTNERS V LP
10% Owner
Transactions
- Purchase
Warrant
2011-07-21$0.14/sh+872,093$122,093→ 872,093 totalExercise: $1.65Exp: 2016-07-26→ Common Stock (872,093 underlying) - Purchase
Common Stock
2011-07-21$1.65/sh+1,744,186$2,877,907→ 4,187,777 total
CRANDELL KEITH
10% Owner
Transactions
- Purchase
Common Stock
2011-07-21$1.65/sh+1,744,186$2,877,907→ 4,187,777 total - Purchase
Warrant
2011-07-21$0.14/sh+872,093$122,093→ 872,093 totalExercise: $1.65Exp: 2016-07-26→ Common Stock (872,093 underlying)
ARCH VENTURE PARTNERS V LLC
10% Owner
Transactions
- Purchase
Common Stock
2011-07-21$1.65/sh+1,744,186$2,877,907→ 4,187,777 total - Purchase
Warrant
2011-07-21$0.14/sh+872,093$122,093→ 872,093 totalExercise: $1.65Exp: 2016-07-26→ Common Stock (872,093 underlying)
BYBEE CLINTON
10% Owner
Transactions
- Purchase
Common Stock
2011-07-21$1.65/sh+1,744,186$2,877,907→ 4,187,777 total - Purchase
Warrant
2011-07-21$0.14/sh+872,093$122,093→ 872,093 totalExercise: $1.65Exp: 2016-07-26→ Common Stock (872,093 underlying)
LAZARUS STEVEN
10% Owner
Transactions
- Purchase
Common Stock
2011-07-21$1.65/sh+1,744,186$2,877,907→ 4,187,777 total - Purchase
Warrant
2011-07-21$0.14/sh+872,093$122,093→ 872,093 totalExercise: $1.65Exp: 2016-07-26→ Common Stock (872,093 underlying)
Footnotes (5)
- [F1]Securities held of record by ARCH Venture Fund V, L.P. ("ARCH V"). ARCH Venture Partners V, L.P. (the "GPLP"), as the sole general partner of ARCH V, may be deemed to beneficially own certain of the shares held of record by ARCH V. The GPLP disclaims beneficial ownership of all shares held of record by ARCH V in which the GPLP does not have an actual pecuniary interest. ARCH Venture Partners V, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by ARCH V. The GPLLC disclaims beneficial ownership of all shares held of record by ARCH V in which it does not have an actual pecuniary interest.
- [F2]In addition to securities held of record by ARCH V, Healthcare Focus Fund, L.P. ("Healthcare") is the record holder of 458,903 securities and ARCH V Entrepreneurs Fund, L.P. ("Entrepreneurs") is the record holder of 11,004 securities. The GPLP, as the sole general partner of Healthcare and Entrepreneurs, may be deemed to beneficially own certain of the shares held of record by Healthcare and Entrepreneurs. The GPLP disclaims beneficial ownership of all shares held of record by Healthcare and Entrepreneurs in which the GPLP does not have an actual pecuniary interest. The GPLLC, as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Healthcare and Entrepreneurs. The GPLLC disclaims beneficial ownership of all shares held of record by Healthcare and Entrepreneurs in which it does not have an actual pecuniary interest.
- [F3]Each of Messrs. Crandell, Bybee, Lazarus and Nelsen, as individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by ARCH V, Healthcare and Entrepreneurs. Each of Messrs. Crandell, Bybee, Lazarus and Nelsen disclaims beneficial ownership of all shares held of record by ARCH V, Healthcare and Entrepreneurs in which he does not have an actual pecuniary interest.
- [F4]The Warrants are immediately exercisable.
- [F5]The Expiration Date is five years from the expected closing date.
Documents
Issuer
NeurogesX Inc
CIK 0001385830
Entity typeother
Related Parties
1- filerCIK 0001117120
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 9:09 PM ET
- Size
- 20.8 KB